sure, pressure reactivity index, and other physiological variables were calculated; clinical events were organized using predefined scales. In 28% of all 1,561 periods, an optimal cerebral perfusion pressure curve was absent. A generalized linear mixed model with binary logistic regression was fitted. Absence of slow arterial blood pressure waves (odds ratio, 2.7; p < 0.001), higher pressure reactivity index values (odds ratio, 2.9; p < 0.001), lower amount of sedative-analgesic drugs (odds ratio, 1.9; p = 0.03), higher vasoactive medication dose (odds ratio, 3.2; p = 0.02), no administration of maintenance neuromuscular blockers (odds ratio, 1.7; p < 0.01), and following decompressive craniectomy (odds ratio, 1.8; p < 0.01) were independently associated with optimal cerebral perfusion pressure curve absence. Conclusions: This study identified six factors that were independently associated with absence of optimal cerebral perfusion pressure curves. (Crit Care Med 2015; 43:1952 -1963 Key Words: cerebral autoregulation; optimal cerebral perfusion pressure; pressure reactivity index; therapy; traumatic brain injury C urrent guidelines for management of severe traumatic brain injury (TBI) patients recommend keeping intracranial pressure (ICP) below 20 mm Hg and cerebral perfusion pressure (CPP) within the range of 50-70 mm Hg (1) . Although some success has been achieved with this approach, it ignores substantial injury-specific and patientspecific variability (2) . Reconsideration of current ideas and approaches was further supported by a recent trial showing lack of any important outcome benefits of applying one particular fixed ICP treatment cutoff (target) value (3) . One of the promising approaches supports the idea of individualizing perfusion treatment strategies guided by the state of cerebral autoregulation (4) (5) (6) .
Cerebrovascular pressure reactivity represents a key element of cerebral blood flow autoregulation. The pressure reactivity index (PRx) can be determined as the moving correlation coefficient between 30 consecutive, 10-second averaged values of mean arterial blood pressure (MAP) and ICP (7) . Various different reactivity indices have been studied with mixed results (8) (9) (10) . The "classical" 5-minute PRx has been positively validated versus the static rate of autoregulation both clinically and experimentally (11, 12) .
The above method incorporates the philosophy of assessing active cerebrovascular reactions by observing the response of cerebral blood volume and subsequently ICP to slow spontaneous changes in arterial blood pressure (ABP) (13) . However PRx is highly variable (noisy) and requires averaging over time (minimal 30 min in normal clinical situations) in order to provide meaningful values. One useful way of "averaging" PRx is to divide its values into different intervals according to corresponding predefined CPP ranges. It turned out that, as an added benefit of such an approach, with only a few hours of ABP and ICP recordings, plotting the PRx index against associated CPP intervals frequently produces a U-shaped curve with both hypoperfusion (low CPP) and hyperperfusion (high CPP) associated with worsened cerebrovascular reactivity (4, 5) . Using dedicated curve fitting software, the lowest point of the individual autoregulation curve can be marked as the "optimal" CPP (CPPopt) value, corresponding to the CPP where the pressure autoregulation is the most effective (equivalent to the middle point of the Lassen autoregulation curve). Recently, we have demonstrated in a single-center retrospective study in more than 300 TBI patients that using a moving calculation window of 4 hours, an individual CPPopt value could be updated automatically every minute in 55% of recording time (4) . Importantly, the results showed that deviation of the actual CPP from the calculated CPPopt was associated with worse clinical outcome. Next steps would be to test the feasibility of introducing the CPPopt-guided TBI treatment in clinical practice and assess its clinical efficacy in a prospective controlled trial. However, understanding the causes for method failure is essential for its improvement, designing a CPPoptbased treatment protocol, and formulating inclusion and exclusion criteria for future studies. This prospective observational two-center study aimed at establishing the relationship between method failure and selected physiological variables, state of autoregulation, clinical factors, and major therapeutic interventions.
MATERIALS AND METHODS

Patients
Severe TBI patients, defined as patients with Glasgow Coma Scale (GCS) score less than 8, admitted to the neurocritical care unit between May 2012 and December 2013 with continuous monitoring of ABP and ICP as part of the TBI monitoring protocol were included. The study was conducted in two academic medical centers (Groningen and Cambridge). In Cambridge, consecutive traumatic brain-injured patients with a clinical need for ICP monitoring were included for analysis. Informed consent was obtained from all patients (or their next of kin) for the use of collected data for research purposes. The study was approved by the relevant research ethics committee (29 REC 97/291). In Groningen, the local medical ethics committee reviewed and waived the need for informed consent. Only patients older than 16 years and with at least 24 hours of continuous monitoring were included. All patients were sedated, intubated, and mechanically ventilated. In both centers, the TBI protocol aimed at keeping the CPP at approximately 60-70 mm Hg and the ICP below 20 mm Hg. In neither center, CPPopt was integrated into the treatment protocol. Patients' demographics and baseline clinical data were collected. Neurologic status was assessed after resuscitation using the GCS and pupil reactivity to light with a conventional flashlight. The Marshall classification for CT scans was used to grade admission CT scans (14) . Clinical outcome was assessed at 6 months using the Glasgow Outcome Scale (GOS).
Data Acquisition
ABP was monitored invasively from the radial or femoral artery with an intravascular catheter connected to a pressure transducer (Baxter Healthcare, CardioVascular Group, Irvine, CA (16) . The sd of ABP and ICP was calculated from 30 consecutive, 10-second averages of ABP and ICP and updated every minute to evaluate the presence of spontaneous slow waves. Since calculation of PRx is dependent on the presence of slow waves, low variance in spontaneous slow waves can affect PRx and thus CPPopt calculation.
Selection of Clinical Variables. From the TBI monitoring and treatment protocols, interventions for managing intracranial hypertension were selected as clinical variables likely affecting systemic and cerebral hemodynamics and therefore cerebral pressure autoregulation state. The "Treatment Intensity Level" score was used as guidance for selection and categorization of variables (17) . Table 1 lists the clinical variables selected for this study and the way of categorization. Tables 2 and 3 list the sedative-analgesic and vasoactive drugs used in both centers. Maintenance neuromuscular blockage with atracurium was routinely applied in Cambridge (18) . The administration of bolus therapy (sedatives, analgesics, neuromuscular blockers, and hyperosmolar agents) was indicated in case of patient transportation (scans/theater), daily nursing care, or as part of the stepwise approach to treatment of intracranial hypertension (19) . The administration of barbiturates, intermittent drainage of cerebrospinal fluid (CSF), applying hypothermia, and status after decompressive craniectomy were evaluated. Medical notes and nursing charts were checked twice daily for changes in these predefined variables by the same two authors (C.S.A.W., M.J.H.A.). Hourly updates of drug rates and concentrations, intermittent CSF drainage (mL/hr), surgical interventions (evacuation of hematoma, decompressive craniectomy, or external ventricular drain [EVD] placement), and hypothermia were annotated in the bedside recording software ICM+.
Data Analysis
After completion of data collection, all physiological signals were checked manually for artifacts and if present subsequently excluded from further calculations. Only patients who were monitored for more than 24 hours were selected for the analyses. A curve-fitting algorithm was used to retrieve the CPPopt value automatically. The method is described in detail elsewhere (4). In summary, for a monitoring period of 4 hours, averaged PRx values are plotted against associated CPP intervals of 5 mm Hg. To the resulting, Fisher transformed, error-bar plot, a parabolic curve is fitted automatically by special software. The CPPopt corresponds to the lowest point on the fitted curve and represents the CPP value where cerebrovascular pressure reactivity is best functioning. If no curve can be fitted, a "not-a-number" is generated. An example of both situations is provided in Figure 1 . During data collection, CPPopt values were available for the clinicians at the bedside, but CPPopt was not integrated in the CPP-guided treatment protocols in neither hospital.
Data from all patients were divided in consecutive 4-hour periods for evaluation of the variables of interest. First, the presence of an automatic CPPopt value was evaluated (present/absent). Since an important criterion for the curve fitting method is availability of a minimum of 2 hours of artifact-free data, only periods with more than 2 hours of ABP and ICP data were selected for method failure analysis (4). Second, for every 4-hour period, mean values of the selected physiological variables were calculated. Third, all the annotated clinical variables were scored (Table 1) .
Statistical Analysis
In order to study the association of predefined physiological and clinical variables with method failure, we calculated the percentage of time (%) that a CPPopt value was absent every 4 hours. The independent effect of predefined variables on method failure was evaluated by a mixed model. The mixed model analysis takes into account the repeated measurements within patients. Differences in periods with and without CPPopt (dependent variable) were assessed, and variables with a p value less than 0.2 in the univariate analysis were selected as covariates for the multivariate analysis. Statistical analysis for categorical data was performed with the chi-square test or Mann-Whitney U test when appropriate. For all categorical variables, the first category was used as the reference group. In the multivariate model, results are expressed as adjusted odds ratio (OR) and corresponding 95% CI. A two-sided p value less than 0.05 was considered as statistically significant. All statistical analyses were performed using SPSS Statistics (released 2011, SPSS, version 20.0, IBM, Armonk, NY). In SPSS, the module generalized linear mixed model was applied, using the binary logistic regression.
RESULTS
Patient Characteristics
Between May 2012 and December 2013, 54 severe TBI patients were monitored in both centers with real-time annotation of predefined events. In total, six patients were excluded with less than 24 hours of data. After inspection of the recordings and artifact removal, 32 patients were eligible for analysis in Cambridge and 16 in Groningen, leaving 48 patients for the final analysis ( Table 4) . The median recording time per patient was 4 days (range, 1-19 d). The median (25th-75th percentile) age was 44 years (23-55 yr). The median (25th-75th percentile) GCS score after resuscitation was 6 Table 2 for further explanation. See Table 3 for further explanation.
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September 2015 • Volume 43 • Number 9 (3) (4) (5) (6) (7) (8) . Patients with initial GCS scores greater than 8 were included in case of neurologic deterioration. The in-hospital mortality was 21%, and 46% of the patients had a favorable outcome at 6 months (GOS 4 and 5).
Physiological and Clinical Variables
The 48 patients were monitored for a total of 6,859 hours ( Table 6 shows the results from univariate analysis of all predefined physiological and clinical variables. etCo 2 (p = 0.99) and CSF drainage (p = 0.22) were not significantly different between periods of curve presence and absence and were excluded from further analysis. Finally, 14 variables were selected for the multivariate analysis. Absence of a CPPopt curve was not associated with outcome (GOS) using simple linear regression analysis (p = 0.40).
Univariate Analysis
Multivariate Analysis
A mixed model was applied with backward stepwise selection of explanatory variables, using absent CPPopt as the response (binary) variable. The patient characteristics-age, gender, and admission CT-Marshall score-were initially included as covariates in the model, but as they did not change the model significantly, they were left out in the final model. Furthermore, hospital site and number of 4-hour periods per patient were included in the model to account for differences between the two centers and for the distribution in monitoring time per patient, 
DISCUSSION
In this observational study, an automated methodology using cerebral pressure reactivity monitoring showed that in more than 70% of monitoring time, an individual perfusion target value (CPPopt), updated 4 hourly, was available at the bedside in TBI patients. Low variance in slow ABP waves, higher values of PRx, low amount of sedative-analgesic drugs, administration of high-dose vasoactive medication, nonadministration of maintenance neuromuscular blockers, and following decompressive craniectomy were all independently associated with CPPopt method failure. We hypothesize that these variables interfere directly or indirectly with reliable PRx and subsequent CPPopt calculation.
Spontaneous AbP Fluctuations and Autoregulation Status
With small magnitude of slow ABP waves, there was an increased likelihood of an absent curve. These results fit with the, rather intuitive, notion that spontaneous slow ABP waves of high enough amplitude are essential for robust and reliable dynamic pressure autoregulation calculations, such as PRx, with good signal-to-noise ratio (7, 20) . A certain minimal span of (ultra) slow ABP fluctuations is needed to probe an acceptable part of the autoregulation curve. For the CPPopt method, this span is defined at 20 mm Hg, with added requirement that it fits within the upper and lower limits of autoregulation set at CPP levels of 40 and 120 mm Hg, respectively (4). In this study, no specific interventions were applied to change absolute ABP levels or to induce slow waves (12) . In theory, the manipulation of ABP to scan across a range of CPP values may improve the reliability of the method, but the safety of these interventions in TBI patients is questionable, time consuming, and probably not suitable for long-term monitoring. On the other hand, with the use of spontaneous ABP fluctuations, an automatic CPPopt calculation rate of 72% was achieved, supporting future applicability of this clinical method in the majority of patients. In 2012, using retrospective data, the CPPopt calculation rate was around 55%. The differences are partly due to differences in methodology. First, prospective data collection resulted in early recognition and restoration of technical failures like accidental disconnections or malfunction of ABP monitoring catheters. Second, in 2012, 4-hour periods with less than 2 hours of data were included. Third, CPPopt was being calculated every minute, as opposed to every 4 hours, which makes direct comparison of rate of failure difficult (4). For clinical practice, an update every 4 hours seems reasonable, justifying our choice in this prospective study.
Higher levels of PRx were associated with absent CPPopt. Consistently high PRx values, irrespective of the level of CPP, are seen in a state of severely and persistently disturbed autoregulation (vasoparalysis), precluding existence of the plateau of the Lassen autoregulation curve. In this case, detection of its "optimal point" is impossible from the very definition. However, the absence of a clear CPPopt maybe a pertinent negative finding of interest in itself, since it makes use of higher CPP values to reduce ICP (through autoregulatory vasoconstriction) inappropriate, and may therefore guide broad strategic approaches to CPP management in such patients (8) . For these situations, other brain monitoring modalities might be helpful to guide precise targets for CPP treatment (21, 22 ).
Level of ICP
The level of ICP was not independently associated with absence of CPPopt in the multivariate analysis, although in univariate analysis there was an association between absolute ICP and absence of CPPopt. Appendix Table B (Supplemental Digital Content 1, http://links.lww.com/CCM/B352) shows that CPPopt is more frequently present in periods with higher ICP levels (defined as ICP > 20 mm Hg). Probably, with higher ICP levels, the relationship between slow fluctuations in ABP and ICP is more robust (steep part of pressure-volume curve), and therefore, it has a positive influence on the PRx-CPPopt methodology (7).
Confounding Factors for CPPopt
Vasoactive Medication. The results showed that the use of high-dose vasoactive medication increased the likelihood of method failure. No specific literature is available to show the direct influence of vasoactive medication (especially norepinephrine) on cerebral vessels, autoregulation, or metabolic compensation in TBI patients (23) (24) (25) . In healthy individuals, the increase in ABP with administration of norepinephrine resulted in an increase in the cerebrovascular tone (due to intact cerebral autoregulation) but not in a significant change in cerebral hemodynamics (26) . Instead of acting directly on cerebral hemodynamics or autoregulation, vasoactive drugs can possibly dampen the spontaneous large ABP fluctuations by increasing peripheral vascular resistance. Furthermore, following the current TBI guidelines, the CPP was very tightly controlled using vasoactive medication, thus keeping the span of CPP changes small and consequently impeding the construction of a reliable U-shaped curve (4).
Sedation and Neuromuscular Blocking Agents.
Propofol, midazolam, and opioids are frequently used for sedation, analgesia, and control of increased ICP in TBI. The literature suggests that in healthy individuals, propofol has beneficial effects on autoregulation indices (27) , but increasing dosages of propofol seemed to impair static and dynamic autoregulation significantly in 10 severe TBI patients (28) . Whether the negative relation between CPPopt method failure and higher sedation-analgesia dosages is drug related or just an indication of more unstable patients with more difficulties controlling ICP and CPP levels allowing autoregulation to be "probed" over a broader range of CPPs is not clear. Neuromuscular blocking agents are administered in TBI patients to support mechanical ventilation, to allow safe transport of patients, and to control prolonged ICP spikes (29) . With administration of maintenance neuromuscular blocking agents (in combination with sedation), it is possible to prevent posturing, shivering, coughing, and ventilator asynchrony. Ventilator asynchrony and coughing, in particular, may cause (transient) increased intrathoracic pressure, impeding cerebral venous outflow. This may cause ICP changes that are not related to ABP counterregulatory mechanisms, thus introducing noise into reliable PRx calculation. This might explain the unexpected negative correlation between the use of neuromuscular blocking agents and the absence of a CPPopt curve. However, here as well, a direct effect on cerebral vessels or autoregulation cannot be excluded. Since neuromuscular blocking agents are commonly used in Cambridge and almost never in Groningen, we tested the interaction between the use of neuromuscular blockers and hospital site. The interaction was not significant, supporting our hypothesis that neuromuscular blocking agents might have an independent influence on CPPopt calculation.
Decompressive Craniectomy. It is not well known whether PRx is a reliable indicator of cerebrovascular pressure reactivity (31) showed improvements in PRx postcraniectomy. The issue here is that after craniectomy, cerebrospinal pressure-volume curve becomes artificially flat, impeding transmission of blood volume changes into ICP, and therefore significantly reducing the signal-to-noise ratio for PRx calculations. As a result, after craniectomy, PRx oscillates around zero, very seldom reaching persistent (averaged) negative values. New methods for testing of cerebrovascular pressure reactivity using amplitude of ICP instead of mean ICP, thus relying more on the cerebrovascular compliance rather than on the pressure-volume characteristic, have been proposed, but so far not evaluated with respect to CPPopt (32). etCo 2 . One physiological factor expected to influence our method was the etCo 2 variability. Paco 2 normally has a major impact on the cerebral arterioles (33) . The fact that this factor was excluded from the model might be explained by the treatment guidelines, which aimed for and achieved a strict, narrow range for Paco 2 values.
Annotations of Clinical Events
For this study, our data collection software (ICM+) was adapted to allow real-time, detailed annotation of clinical events, nursing events, and medication changes. As shown in this article, some of those events seem to have important influence on autoregulation calculation and treatment algorithms (e.g., CPPopt orientated) and improve our understanding of current (aggressive) treatments. Inclusion of clinical annotation into the multimodal monitoring data analysis models may perhaps make the measurements/calculations more reliable and make validation studies more replicable and thus more meaningful.
Limitations
This study was performed in two trauma referral centers where the treatment algorithms for intracranial hypertension are largely comparable. Our data show that in both centers, CPP levels above the guideline targets are applied (> 70 mm Hg). As CPPopt calculation depends heavily on the applied CPP range, high CPPopt levels were found. This highlights the importance of studying CPPopt behavior across multiple centers with (potentially) different local CPP targets. A selection of 16 clinical and physiological variables was tested in our model in two centers with long-term recordings in 48 patients. Using a nonvalidated scale for the amount of sedative-analgesic and vasoactive drugs is a limitation for this study but inevitable because a validated scale is not available. In order to study the 16 variables in a relatively small number of patients, (manual) exclusion of artifacts was important. For future prospective studies, it would be interesting to explore the influence of technical errors and use of automatic artifact removing tools on CPPopt calculation. Furthermore, a larger patient sample in more centers would provide more reliable conclusions. This limitation was partially addressed by treating every 4-hour period as an independent sample and adding the number of periods per patient and hospital site as confounding factors in our mixed model. The number of periods per patient was a significant confounder, but with an OR of 1.0 (ratio rounded to the first decimal place) of negligible importance. No significant linear interactions were found between individual variables in the final model. More complex interactions between therapy, physiological variables, intracranial pathology, and our CPPopt model probably exist, but these cannot be tested separately in a clinical setting with limited number of heterogeneous patients. Finally, we cannot rule out that events were missed due to omissions or mistakes in medical and nursing charts and limited corrections by our twice daily evaluation. Nevertheless, we feel that our results provide a good foundation for designing a CPPopt feasibility protocol.
Future Perspectives
This prospective study provides important insights into an innovative method, using up-to-date information of cerebrovascular pressure reactivity status to guide individual treatment. The sample size of the current prospective database limits the possibility to establish all the clinical factors that are related to the method failure. However, our results already provide useful data that will inform design of upcoming prospective CPPopt feasibility and outcome studies. First, as with every pressure autoregulation study that uses spontaneous waveform analysis, slow ABP waves of sufficient amplitude are essential for obtaining reliable results. Additionally, ultraslow fluctuations of ABP (on the scale of hours) spanning a range of at least 20-30 mm Hg are the sine qua non for the CPPopt method. Clinicians need to understand that in cases when those oscillations are absent, the CPPopt method cannot be used. Second, interaction between the use of medications and method failure deserves further attention. Third, our data raise the possibility that decompressive craniectomy may preclude use of the technique. Last, any feasibility trial protocols should impose a necessity of detailed clinical annotation to aid interpretation of the monitoring data.
CONCLUSIONS
This observational study identified physiological and clinical factors that were independently associated with absence of the CPPopt curve. The study provides additional information for future CPPopt-oriented therapy, which is an attractive concept. However, future TBI management protocols incorporating this concept may need to include various carefully constructed exclusion and inclusion criteria as well as offer strategies for coping with its transient inadequacies. A welldesigned feasibility study could help to shape such a protocol and is a much-needed step before any other comparative effectiveness trials could be performed on this promising methodology.
